Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
PureTech Health (LSE: PRTC, Nasdaq: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing highly differentiated medicines for devastating diseases. The company is advancing a neuroscience and immunology pipeline, built on its expertise in the brain-immune-gut (BIG) axis. PureTech's programs are focused on areas of significant unmet medical need, including neurological and neuropsychological conditions, and inflammatory and immunological diseases. The company operates with a hub-and-spoke business model, progressing its own wholly-owned programs and also founding and supporting innovative Founded Entities.
The Boston headquarters serves as the central hub for PureTech's global operations, including strategic leadership, research and development oversight, clinical trial management, business development, investor relations, and administrative functions.
Located in Boston's Seaport District, a vibrant and growing innovation hub, offering modern facilities designed to foster collaboration and scientific advancement. The office likely features open-plan areas, meeting spaces, and technology to support a dynamic biotech company.
The work culture at PureTech Health is expected to be science-driven, innovative, and collaborative, with a strong focus on achieving breakthroughs for patients. Employees are likely passionate about tackling complex medical challenges in a fast-paced environment.
Boston's ecosystem provides unparalleled access to world-class academic institutions, research talent, a skilled workforce, venture capital, and a dense network of other biotech and pharmaceutical companies, facilitating collaborations and partnerships.
PureTech Health's primary operational headquarters is in Boston, USA, with a registered office in London, UK. Its global presence is further established through its clinical trials conducted in multiple countries, collaborations with international research institutions and pharmaceutical companies, and the worldwide commercial potential of its therapeutic candidates. Its Founded Entities may also have their own distinct international operations and partnerships.
6 Tide Street, Suite 400
Boston
MA
USA
Address: Floor 5, 150 Minories, London, EC3N 1LS, UK (Registered Office)
Facilitates compliance with UK listing requirements, engagement with European investors, and potentially supports business development and clinical operations within Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, PureTech Health' leadership includes:
PureTech Health has been backed by several prominent investors over the years, including:
PureTech Health has seen key appointments in its executive team over the past year, notably strengthening its financial leadership.
Discover the tools PureTech Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
PureTech Health likely uses common corporate email formats. Based on industry standards, the most probable formats are [first_initial][last]@puretechhealth.com or [first].[last]@puretechhealth.com.
[first_initial][last]@puretechhealth.com
Format
jdoe@puretechhealth.com
Example
80%
Success rate
PureTech Health Website • May 29, 2024
PureTech Health presented new preclinical mechanistic data and clinical Positron Emission Tomography (PET) data for LYT-300 (oral allopregnanolone). The data supports LYT-300's novel mechanism of action and its ability to achieve brain exposure and target engagement at levels known to be therapeutic....more
PureTech Health Website • May 21, 2024
PureTech announced the publication of preclinical data in Nature Communications detailing the mechanism of LYT-200. The findings show LYT-200's potential to target immunosuppressive myeloid cells and enhance anti-tumor immunity, particularly in challenging cancers like pancreatic ductal adenocarcinoma (PDAC)....more
PureTech Health Website • May 14, 2024
PureTech Health plc announced the appointment of Joe Miller, M.B.A., as Chief Financial Officer, effective May 13, 2024. Mr. Miller brings over 20 years of financial and operational experience in the biopharmaceutical industry to PureTech....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including PureTech Health, are just a search away.